| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |